Study birth control timing in HIV, using blood tests
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study looks at how well HIV treatment (ART) and a hormonal birth control method (DMPA shot or implant) work together, using small blood samples. It may help ensure safer, more effective HIV care and contraception for young women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female age 15–24 when you enroll (or at least 18 for provider/policy interviews)
- You either have HIV with recent viral suppression (or, if HIV-uninfected group is used, you are not living with HIV)
- Your HIV viral load was suppressed to under 40 copies/mL within the last 6 months
- You are willing to have blood drawn every 4–12 weeks for the study
- If you are in the HIV/PK groups: you have been on the study HIV medicine at least 4 weeks, and plan to use DMPA or the implant for at least 3–6 more months
- You can consent (or assent with a parent/guardian) in English or Kiswahili
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well two different pill combinations work together to prevent HIV and pregnancy. You'll take daily birth control pills and daily HIV prevention pills, and researchers will check your health regularly for about a year.
This research studies how two types of long-acting birth control (a shot called cabotegravir and an implant) work in your body after pregnancy, and how they interact with HIV prevention or treatment. The study helps doctors understand the best doses and timing for women like you.
This study tests a long-acting HIV prevention shot (Cabotegravir) or a vaginal ring (DapiRing) along with sexual health services for young people. It aims to find the best way to prevent HIV and support overall health.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study measures how HIV medicines move through your body during pregnancy by collecting blood samples after you take your regular treatment. It may help improve understanding of dosing and drug levels in pregnant people living with HIV.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.